Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume 43, Issue 2, Pages 1189-1203
Publisher
Oxford University Press (OUP)
Online
2014-12-31
DOI
10.1093/nar/gku1362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
- (2014) S. J. Scales et al. MOLECULAR CANCER THERAPEUTICS
- Site-Specific Antibody–Polymer Conjugates for siRNA Delivery
- (2013) Hua Lu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Real-time quantification of antibody–short interfering RNA conjugate in serum by antigen capture reverse transcription–polymerase chain reaction
- (2012) Martha Tan et al. ANALYTICAL BIOCHEMISTRY
- Antibody-Drug Conjugates in Cancer Therapy
- (2012) Eric L. Sievers et al. Annual Review of Medicine
- Antibody-Conjugated Nanoparticles for Therapeutic Applications
- (2012) M. M. Cardoso et al. CURRENT MEDICINAL CHEMISTRY
- Anti-Her2 single-chain antibody mediated DNMTs-siRNA delivery for targeted breast cancer therapy
- (2012) Shuang Dou et al. JOURNAL OF CONTROLLED RELEASE
- Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers
- (2012) Kristina W. Thiel et al. NUCLEIC ACIDS RESEARCH
- Targeted Delivery of PLK1-siRNA by ScFv Suppresses Her2+ Breast Cancer Growth and Metastasis
- (2012) Y.-d. Yao et al. Science Translational Medicine
- An Antibody-Drug Conjugate Targeting the Endothelin B Receptor for the Treatment of Melanoma
- (2011) J. Asundi et al. CLINICAL CANCER RESEARCH
- Cargo sorting to lysosome-related organelles regulates siRNA-mediated gene silencing
- (2011) Dinari A. Harris et al. JOURNAL OF CELL BIOLOGY
- Current prospects for RNA interference-based therapies
- (2011) Beverly L. Davidson et al. NATURE REVIEWS GENETICS
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Silencing by small RNAs is linked to endosomal trafficking
- (2009) Young Sik Lee et al. NATURE CELL BIOLOGY
- Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity
- (2009) Derrick J. Gibbings et al. NATURE CELL BIOLOGY
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice
- (2008) Priti Kumar et al. CELL
- Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs
- (2008) Jagath R. Junutula et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Localization of Double-stranded Small Interfering RNA to Cytoplasmic Processing Bodies Is Ago2 Dependent and Results in Up-Regulation of GW182 and Argonaute-2
- (2008) Aarti Jagannath et al. MOLECULAR BIOLOGY OF THE CELL
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now